Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
The Pharma Letter
55m
EC grants approval for AbbVie’s Elahere in ovarian cancer
AbbVie says that Elahere is the first and only folate receptor alpha (FRÉ‘)-directed antibody drug conjugate (ADC) medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Files for bankruptcy
Transportation secretary pick
Election officials rebuked
Windsor burglary probe
Moscow warns US
Condemns neo-Nazi march
Bulls legend dies at 81
Russia vetoes UN resolution
To perform at NFL halftime
To cut workforce
GA court cancels hearing
FAU fires coach
NBA YoungBoy pleads guilty
Debris falls from roof
Rookie of the Year winners
Settler group sanctioned
NYC issues drought warning
US opens two new probes
Enters race for DNC chair
Huckabee's Meta suit tossed
Riley murder trial resumes
Travel guide innovator dies
Labor agency dispute
Border wall trial delayed
NYC congestion pricing plan
2nd-oldest US resident dies
Former soldier sentenced
Driver's bias verdict reduced
Disaster relief funding bill
WY abortion laws rejected
Seeks Capitol bathroom ban
‘One Tree Hill' actor dies
Russian ballet star dies
Related topics
AbbVie
European Union
Ovarian cancer
Feedback